Newborn Screening for Presymptomatic Diagnosis of Complement and Phagocyte Deficiencies
Overview
Authors
Affiliations
The clinical outcomes of primary immunodeficiencies (PIDs) are greatly improved by accurate diagnosis early in life. However, it is not common to consider PIDs before the manifestation of severe clinical symptoms. Including PIDs in the nation-wide newborn screening programs will potentially improve survival and provide better disease management and preventive care in PID patients. This calls for the detection of disease biomarkers in blood and the use of dried blood spot samples, which is a part of routine newborn screening programs worldwide. Here, we developed a newborn screening method based on multiplex protein profiling for parallel diagnosis of 22 innate immunodeficiencies affecting the complement system and respiratory burst function in phagocytosis. The proposed method uses a small fraction of eluted blood from dried blood spots and is applicable for population-scale performance. The diagnosis method is validated through a retrospective screening of immunodeficient patient samples. This diagnostic approach can pave the way for an earlier, more comprehensive and accurate diagnosis of complement and phagocytic disorders, which ultimately lead to a healthy and active life for the PID patients.
A Non-targeted Proteomics Newborn Screening Platform for Inborn Errors of Immunity.
Shibata H, Nakajima D, Konno R, Hijikata A, Higashiguchi M, Nihira H J Clin Immunol. 2024; 45(1):33.
PMID: 39453496 PMC: 11511704. DOI: 10.1007/s10875-024-01821-7.
Proteome profiling of home-sampled dried blood spots reveals proteins of SARS-CoV-2 infections.
Fredolini C, Dodig-Crnkovic T, Bendes A, Dahl L, Dale M, Albrecht V Commun Med (Lond). 2024; 4(1):55.
PMID: 38565620 PMC: 10987641. DOI: 10.1038/s43856-024-00480-4.
Genomic-Based Newborn Screening for Inborn Errors of Immunity: Practical and Ethical Considerations.
King J, Grill K, Hammarstrom L Int J Neonatal Screen. 2023; 9(2).
PMID: 37092516 PMC: 10123688. DOI: 10.3390/ijns9020022.
Current State and Innovations in Newborn Screening: Continuing to Do Good and Avoid Harm.
la Marca G, Carling R, Moat S, Yahyaoui R, Ranieri E, Bonham J Int J Neonatal Screen. 2023; 9(1).
PMID: 36975853 PMC: 10057559. DOI: 10.3390/ijns9010015.
Future Perspectives of Newborn Screening for Inborn Errors of Immunity.
Blom M, Bredius R, van der Burg M Int J Neonatal Screen. 2021; 7(4).
PMID: 34842618 PMC: 8628921. DOI: 10.3390/ijns7040074.